Jump to content

User:Lr775/Controversies about psychiatry

From Wikipedia, the free encyclopedia
< User:Lr775

This is an old revision of this page, as edited by Lr775 (talk | contribs) at 03:32, 9 April 2022. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Note to peer reviewers:

The bulk of our work is the "history of racism" section, which we wrote in its entirety. The rest of our work is smaller edits to the language/ grammar of the page, because it was pretty poorly written/ edited -- those changes are bolded throughout the other sections.

Controversies about psychiatry

Psychiatry is, and has historically been, viewed as controversial by those under its care, as well as sociologists and psychiatrists themselves. There are a variety of reasons cited for this controversy, including the subjectivity of diagnosis,[1] the use of diagnosis and treatment for social and political control including detaining citizens and treating them without consent,[2] and the side effects of treatments such as electroconvulsive therapy,[3] antipsychotics[4] and historical procedures like the lobotomy[5]: 28  and other forms of psychosurgery[5] or insulin shock therapy.[6]

There are a number of groups who are either critical towards psychiatry or entirely hostile to the field. The Critical Psychiatry Network is a group of psychiatrists who are critical of psychiatry. Additionally, there are self-described psychiatric survivor groups such as MindFreedom International and religious groups such as Scientologists that are critical towards psychiatry.

Challenges to Conceptions of Mental Illness

Since the 1960s there have been challenges to the concept of mental illness. Sociologists Erving Goffman and Thomas Scheff argued that mental illness was merely another example of how society labels and controls non-conformists,[7]: 102  behavioral psychologists challenged psychiatry's fundamental reliance on unobservable phenomena[citation needed], and gay rights activists criticized the APA's inclusion of homosexuality as a mental disorder in the DSM. As societal views on homosexuality have changed in recent decades, it is no longer considered a mental illness and is more widely accepted by society. As another example that challenged conceptions of mental illness, a widely publicized study by Professor David Rosenhan was viewed as an attack on the efficacy of psychiatric diagnosis.[8] However, the neutrality and validity of the project is nowadays often questioned.[citation needed]

Medicalization

Medicalization, a concept in medical sociology, is the process by which human conditions and problems come to be defined and treated as medical conditions, and thus become the subject of medical study, diagnosis, prevention, or treatment. Medicalization can be driven by new evidence or hypotheses about conditions, by changing social attitudes or economic considerations, or by the development of new medications or treatments.

For many years, several psychiatrists, such as David Rosenhan, Peter Breggin, Paula Caplan, Thomas Szasz, and critics outside the field of psychiatry, such as Stuart A. Kirk, have "been accusing psychiatry of engaging in the systematic medicalization of normality".[9] More recently these concerns have come from insiders who have worked for the APA themselves (e.g., Robert Spitzer, Allen Frances).[10]: 185  For example, in 2013, Allen Frances said that "psychiatric diagnosis still relies exclusively on fallible subjective judgments rather than objective biological tests".[11][12]

The concept of medicalization was devised by sociologists to explain how medical knowledge is applied to behaviors which are not self-evidently medical or biological.[13] The term medicalization entered the sociology literature in the 1970s in the works of Irving Zola, Peter Conrad and Thomas Szasz, among others. These sociologists viewed medicalization as a form of social control in which medical authority expanded into domains of everyday existence, and they rejected medicalization in the name of liberation. This critique was embodied in works such as Conrad's "The discovery of hyperkinesis: notes on medicalization of deviance", published in 1973 (hyperkinesis was the term then used to describe what we might now call ADHD), and Szasz's "The Myth of Mental Illness."[14]

These sociologists did not believe medicalization to be a new phenomenon, arguing that medical authorities had always been concerned with social behavior and traditionally functioned as agents of social control (Foucault, 1965; Szasz, 1970; Rosen). However, these authors took the view that increasingly sophisticated technology had extended the potential reach of medicalization as a form of social control, especially in terms of "psychotechnology" (Chorover, 1973).

In the 1975 book Limits to medicine: Medical nemesis (1975), Ivan Illich put forth one of the earliest uses of the term "medicalization". Illich, a philosopher, argued that the medical profession harms people through iatrogenesis, a process in which illness and social problems increase due to medical intervention. Illich saw iatrogenesis occurring on three levels: the clinical, involving serious side effects worse than the original condition; the social, whereby the general public is made docile and reliant on the medical profession to cope with life in their society; and the structural, whereby the idea of aging and dying as medical illnesses effectively "medicalized" human life and left individuals and societies less able to deal with these natural processes.

Marxists such as Vicente Navarro (1980) linked medicalization to an oppressive capitalist society. They argued that medicine disguised the underlying causes of disease, such as social inequality and poverty, and instead presented health as an individual issue. Others examined the power and prestige of the medical profession, including use of terminology to mystify and of professional rules to exclude or subordinate others.[15]

Some argue that in practice the process of medicalization tends to strip subjects of their social context, so they come to be understood in terms of the prevailing biomedical ideology, resulting in a disregard for overarching social causes such as unequal distribution of power and resources.[16] A series of publications by Mens Sana Monographs have focused on medicine as a corporate capitalist enterprise.[17][18][19]

Political Abuse

In unstable countries, political prisoners are sometimes confined and abused in mental institutions.[20]: 3  The diagnosis of mental illness allows the state to hold persons against their will and insist upon therapy in their interest and in the broader interests of society.[21] In addition, receiving a psychiatric diagnosis can in and of itself be regarded as oppressive.[22]: 94  In a monolithic state, psychiatry can be used to bypass standard legal procedures for establishing guilt or innocence and allow political incarceration without the ordinary odium attaching to such political trials.[21] The use of hospitals instead of jails prevents the victims from receiving legal aid before the courts, makes indefinite incarceration possible, and discredits the individuals and their ideas.[23]: 29  In that manner, whenever open trials are undesirable, they are avoided.[23]: 29 

Examples of political abuse of the power, entrusted in physicians and particularly psychiatrists, are abundant in history and seen during the Nazi era and the Soviet rule when political dissenters were labeled as "mentally ill" and subjected to inhumane "treatments."[24] In the period from the 1960s up to 1986, abuse of psychiatry for political purposes was reported to be systematic in the Soviet Union, and occasional in other Eastern European countries such as Romania, Hungary, Czechoslovakia, and Yugoslavia.[21] The practice of incarceration of political dissidents in mental hospitals in Eastern Europe and the former USSR damaged the credibility of psychiatric practice in these states and entailed strong condemnation from the international community.[25] Political abuse of psychiatry also takes place in the People's Republic of China[26] and in Russia.[27] Psychiatric diagnoses such as the diagnosis of 'sluggish schizophrenia' in political dissidents in the USSR were used for political purposes.[28]: 77 

History of Racism

The history of racism in psychiatry dates back to the days of slavery and segregation in the United States. Psychiatric diagnoses were influenced by Black peoples’ enslaved vs. free status, as enslaved people were not considered civilized enough to be diagnosed with insanity.[29] On the other hand, free Black people were over-diagnosed with insanity, having much higher diagnosis rates than white people.[29] In fact, specific diagnoses in the 19th century were crafted specifically to fit Black people – drapetomania and dyaesthesia aethiopica, disorders meant to explain why slaves ran away and why they are lazy and lack a strong work ethic, respectively.[29] Prominent political figures such as John C. Calhoun used this supposed ‘evidence’ as reasoning for why slavery must be upheld, arguing that free Black people could not be entrusted with their lives and would ultimately develop lunacy.[29] Many psychiatric hospitals in the 19th century either excluded or segregated Black patients or admitted Black slaves to work at the hospital in exchange for care.[29] However, Black slaves could only be admitted if their owners paid the bill, creating an obstacle to access for many patients.[29] The founding fathers of psychiatry themselves supported the notion that Black people were inferior, lower class citizens that must be treated separately and differently from white patients.[29] All in all, throughout the 1800s, psychiatric diagnoses and theories were used to uphold systems of slavery and racism and further constrain the rights, freedom, and humanity of Black people.

With time, racial segregation within hospitals became interspersed with entirely separate hospitals for white and Black patients, each with differential treatment and quality of care. Many hospitals, especially in southern America, did not admit Black patients until they were eventually mandated to do so.[30] The last segregated hospital opened in 1933.[30] Political figures in the post-Civil War era argued that emancipation had led to a significant increase in insanity cases amongst Black individuals, and they cited the need to accommodate this increase via segregated and Black-only insane asylums.[30] Popular arguments also circulated that Black patients were more difficult to take care of in mental institutions, making psychiatric care for them more difficult.

Experts have historically attempted to “prove” that Black people are physiologically and cognitively inferior to white people based on faulty assumptions and prejudices. Perpetuated through the inaccurate application of biodeterminism, specialists in neuroanatomy and psychiatrists compared disproportionate amounts of brains from Black and white individuals to support their racial agendas based on “science.” [31] The proportion of Black individuals confined in establishments for "flawed and imbecile" patients surged throughout the late 19th and early 20th century.[32] Psychiatry contributed towards the belief that if they were left to their respective means, they would not be able to remain in decent condition.[32] Because higher-order cognition was fundamentally impossible for black individuals’ brains the "weak" and other "unwanted" communities were targeted by the eugenics and sterilization initiatives.[33] The premise that the genes of those deemed mentally ill were considered “undesirable” was used to justify the unlawful sterilization operations frequently supervised by physicians, even psychiatrists.[33] The number of those affected by these racist and unjust acts on vulnerable populations contributes to the lost history of Black individuals.

Until the late 1960s, many hospitals remained segregated.[34] This extended into the experiences of racial minorities accessing psychiatric care in mental institutions and hospitals in the United States. When Lyndon B. Johnson's administration stated that no segregated hospital would receive federal Medicare funds, hospitals began to integrate quickly in order to be able to continue to access such funding.[34] In January 1966, around two-thirds of Southern hospitals were segregated facilities and many Northern facilities remain segregated in-effect.[34] One year later, by January 1967, there were very few hospitals in the United States that remained segregated. Segregation within mental institutions and hospitals is one example of the history of racism within psychiatry.

During the Civil Rights Movement, Black psychiatrists expressed concerns to the APA that the needs of Black communities and Black psychiatrists were being ignored by the professional organization.[35] In 1969, a contingent of Black psychiatrists presented a list of 9 concerns to the APA Board of Trustees regarding experiences of structural racism in the field.[35] Their '9 points' represented a wide array of experiences of discrimination, both from the experiences of practitioners and patients, and on the institutional and individual level and the group was demanding change from within the APA.[35] For example, they called for more Black leaders on APA committees as well as the desegregation of all mental health facilities, both public and private, in the United States.[35] The work of Black psychiatrists during this period in American history attempted to expose change the institutional racism that functioned within the APA and demand specific changes from the organization to ameliorate this discrimination.

As of 2020, within psychiatry, historically underrepresented groups continue to be less represented as residents, faculty, and practicing physicians in comparison to their proportion in the U.S. population.[36]

Nature of Diagnosis

Arbitrariness

Psychiatry has been criticized for its broad range of mental diseases and disorders. Which diagnoses exist and are considered valid have changed over time depending on society's norms. Homosexuality was considered a mental illness but due to changing attitudes, it is no longer recognised as an illness.[37] Historic disorders that are no longer recognised include orthorexia nervosa, sexual addiction, parental alienation syndrome, pathological demand avoidance, and Internet addiction disorder. New disorders include compulsive hoarding and binge eating disorder.[38]

The act of diagnosis itself has been criticized for being arbitrary with some conditions being overdiagnosed.[39] Individuals may be diagnosed with a mental disorder despite having been perceived as having no issues with their behavior. In Virginia, U.S., it was found up to 33% of white boys are diagnosed with ADHD leading to alarm in the medical community.[40]

Thomas Szasz argued that mental health diagnoses were used as a form of labelling violations of societies norms. Bill Fullford, introduced the idea of "value-laden" mental health diagnosis with mental health lying between physical health and a moral judgment. Under this system personality disorders are seen as not very factual and very value-laden while delirium is quite factual and not very value-laden.[41]: 104 

Biological basis

In 2013, psychiatrist Allen Frances said that he believes that "psychiatric diagnosis still relies exclusively on fallible subjective judgments rather than objective biological tests".[42][43][44]

Mary Boyle argues that psychiatry is actually the study of behavior, but acts as if it is the study of the brain based on a presumed connection between patterns of behavior and the biological function of the brain. She argues that in the case of schizophrenia it is the bizarre behavior of individuals that justifies the presumption of a biological cause for this behavior rather than the existence of any evidence.[45]: 236 

She argues that the concept of schizophrenia and its biological basis serves a social function for psychiatrists. She views the concept of schizophrenia is necessary for psychiatry to be considered as a medical field, that the claimed biological link gives psychiatrists protection from accusations of social control. And that the belief in the biological basis for schizophrenia is maintained through secondary source's misrepresentation of underlying data. She argues that schizophrenia and its biological basis also gives families, psychiatrists and society as a whole the ability to avoid blame for the damage they cause individuals and the ineffectiveness of treatment.[45]: 238 

Schizophrenia diagnosis

Main article: Diagnosis of schizophrenia

Underlying issues associated with schizophrenia would be better addressed as a spectrum of conditions[46] or as individual dimensions along which everyone varies rather than by a diagnostic category based on an arbitrary cut-off between normal and ill.[47] This approach appears consistent with research on schizotypy, and with a relatively high prevalence of psychotic experiences, mostly non-distressing delusional beliefs, among the general public.[48][49][50] In concordance with this observation, psychologist Edgar Jones, and psychiatrists Tony David and Nassir Ghaemi, surveying the existing literature on delusions, pointed out that the consistency and completeness of the definition of delusion have been found wanting by many; delusions are neither necessarily fixed nor false, and need not involve the presence of incontrovertible evidence.[51][52][53]

Nancy Andreasen has criticized the current DSM-IV and ICD-10 criteria for sacrificing diagnostic validity for the sake of artificially improving reliability[citation needed]. She argues that overemphasis on psychosis in the diagnostic criteria, while improving diagnostic reliability, ignores more fundamental cognitive impairments that are harder to assess due to large variations in presentation.[54][55] This view is supported by other psychiatrists.[56] In the same vein, Ming Tsuang and colleagues argue that psychotic symptoms may be a common end-state in a variety of disorders, including schizophrenia, rather than a reflection of the specific etiology of schizophrenia, and warn that there is little basis for regarding DSM's operational definition as the "true" construct of schizophrenia.[46] Neuropsychologist Michael Foster Green went further in suggesting the presence of specific neurocognitive deficits may be used to construct phenotypes that are alternatives to those that are purely symptom-based. These deficits take the form of a reduction or impairment in basic psychological functions such as memory, attention, executive function and problem solving.[57][58]

The exclusion of affective components from the criteria for schizophrenia, despite their ubiquity in clinical settings, has also caused contention. This exclusion in the DSM has resulted in a "rather convoluted" separate disorder—schizoaffective disorder.[56] Citing poor interrater reliability, some psychiatrists have totally contested the concept of schizoaffective disorder as a separate entity.[59][60] The categorical distinction between mood disorders and schizophrenia, known as the Kraepelinian dichotomy, has also been challenged by data from genetic epidemiology.[61]

ADHD

Main article: Attention deficit hyperactivity disorder controversies

ADHD, its diagnosis, and its treatment have been controversial since the 1970s.[62][63][64] The controversies involve clinicians, teachers, policymakers, parents, and the media. Positions range from the view that ADHD is within the normal range of behavior[65][66] to the hypothesis that ADHD is a genetic condition.[67] Other areas of controversy include the use of stimulant medications in children,[63][68] the method of diagnosis, and the possibility of overdiagnosis.[68] In 2012, the National Institute for Health and Care Excellence, while acknowledging the controversy, states that the current treatments and methods of diagnosis are based on the dominant view of the academic literature.[65] In 2014, Keith Conners, one of the early advocates for recognition of the disorder, spoke out against overdiagnosis in an article in The New York Times.[69] In contrast, a 2014 peer-reviewed medical literature review indicated that ADHD is underdiagnosed in adults.[70]

With widely differing rates of diagnosis across countries, states within countries, races, and ethnicities, some suspect factors other than the presence of the symptoms of ADHD are playing a role in diagnosis.[71] Some sociologists consider ADHD to be an example of the medicalization of deviant behavior, that is, the turning of the previously non-medical issue of school performance into a medical one.[62][72] Most healthcare providers accept ADHD as a genuine disorder, at least in the small number of people with severe symptoms.[72] Among healthcare providers the debate mainly centers on diagnosis and treatment in the much larger number of people with less severe symptoms.[72][73][74]

As of 2009, 8% of all United States Major League Baseball players had been diagnosed with ADHD, making the disorder common among this population. The increase coincided with the League's 2006 ban on stimulants, which has raised concern that some players are mimicking or falsifying the symptoms or history of ADHD to get around the ban on the use of stimulants in sport.[75]

Treatment

Psychosurgery

See also: History of psychosurgery

Psychosurgery is brain surgery with the aim of changing an individuals behavior or psychological function. Historically, this was achieved by the removal of a lesion on a section of the brain in ablative psychosurgery but more recently deep brain stimulation is used to remotely stimulate sections of the brain.

One such practice was the lobotomy, that was used between the 1930s and 1950s,[76]: 20  for which one its creators, António Egas Moniz, received a Nobel Prize in 1949.[77] The lobotomy fell out of favor in by 1960s and 1970s.[78] Other forms of ablative psychosurgery were in use in the UK in the late 1970s to treat psychotic and mood disorders.[79] Bilateral cingulotomy was used to treat substance abuse disorder in Russia until 2002. Deep brain stimulation is used in China to treat substance abuse disorders.[80]

In the US, the lobotomy, while initially received with positivity in the late 1930s, came to be seen more negative in the late 1940s and early 1950s. The New York Times discussed the personality changes of lobotomy in 1947, and in the same year the Science Digest reported on papers questioning the effects of lobotomy on personality and intelligence.[81] The lobotomy was prominently depicted a means to control nonconformity in the 1962 book One Flew Over the Cuckoo's Nest.[82]: 70 

Psychosurgery was criticized in the US in the late 1960s and 1970s by psychiatrist Peter Breggin. He identified all psychosurgery with the lobotomy as a rhetorical device to criticize the practice of psychosurgery more broadly.[82]: 116  He stated that "psychosurgery is a crime against humanity, a crime that cannot be condoned on medical, ethical, or legal grounds". Psycho-surgeons William Beecher Scoville and Petter Lindström said that Breggin's critique was emotional and not based on facts.[82]: 121 

Psychosurgery was investigated by the US Senate in the 1973 by the Health Subcommittee of the Senate's Committee on Labor and Public Welfare chaired by Senator Edward Kennedy due to growing concern about the ethical boundaries of science and medicine. At this committee Breggin argued that newer forms of psychosurgery were the same as the lobotomy since it had the same effects "emotional blunting, passivity, reduced capacity to learn" and said that psycho-surgeons "represent the greatest future threat that we are going to face for our traditional American values", arguing that if the US became a totalitarian regime lobotomy and psychosurgery would be the equivalent of the secret police. The subcommittee published a report in 1977 suggesting that data should be carefully collected about psychosurgery and that it should not be performed upon children or prisoners.[82]: 123 

Electroconvulsive therapy

Electroconvulsive therapy is a therapy method which was used widely between the 1930s and 1960s and is, in a modified form, still used today.[83][84] Electroconvulsive therapy was one treatment that the anti-psychiatry movement wanted to be eliminated from psychiatric practice.[85] Their arguments were that ECT damages the brain,[85] and was used as punishment or as a threat to keep the patients "in line".[85] Since then, ECT has improved considerably,[86][87] and is now performed under general anesthesia in a medically supervised environment.[88]

The National Institute for Health and Care Excellence recommends ECT for the short-term treatment of severe, treatment-resistant depression, and advises against its use in schizophrenia.[89][90] According to the Canadian Network for Mood and Anxiety Treatments, ECT is more efficacious for the treatment of depression than antidepressants, with a response rate of 90% in first line treatment and 50-60% in treatment-resistant patients.[91]

The most common side effects of ECT include headache, muscle soreness, confusion, and temporary loss of recent memory.[92][88][93]

Marketing of antipsychotic drugs

Psychiatry has greatly benefitted by advances in pharmacotherapy.[94]: 110–112 [95] However, the close relationship between those prescribing psychiatric medication and pharmaceutical companies, and the risk of a conflict of interest,[95] is also a source of concern. This marketing by the pharmaceutical industry has an influence on practicing psychiatrists, which affects prescription.[95] Child psychiatry is one of the areas in which prescription of psychotropic medication has grown massively. In the past, prescription of these medications for children was rare, but nowadays child psychiatrists prescribe psychotropic substances, such as Ritalin, on a regular basis to children.[94]: 110–112 

Joanna Moncrieff has argued that antipsychotic drug treatment is often undertaken as a means of control rather than to treat specific symptoms experienced by the patient.[96] Moncreiff has further argued, in the controversial and non-peer reviewed journal Medical Hypotheses, that the evidence for antipsychotics from discontinuation-relapse studies may be flawed, because they do not take into account that antipsychotics may sensitize the brain and provoke psychosis if discontinued, which may then be wrongly interpreted as a relapse of the original condition.[97]

Use of this class of drugs has a history of criticism in residential care. As the drugs used can make patients calmer and more compliant, critics claim that the drugs can be overused. Outside doctors can feel pressure from care home staff.[98] In an official review commissioned by UK government ministers it was reported that the needless use of antipsychotic medication in dementia care was widespread and was linked to 1800 deaths per year.[99][100] In the US, the government has initiated legal action against the pharmaceutical company Johnson & Johnson for allegedly paying kickbacks to Omnicare to promote its antipsychotic risperidone (Risperdal) in nursing homes.[101]

There has also been controversy about the role of pharmaceutical companies in marketing and promoting antipsychotics, including allegations of downplaying or covering up adverse effects, expanding the number of conditions or illegally promoting off-label usage; influencing drug trials (or their publication) to try to show that the expensive and profitable newer atypicals were superior to the older cheaper typicals that were out of patent[citation needed]. Following charges of illegal marketing, settlements by two large pharmaceutical companies in the US set records for the largest criminal fines ever imposed on corporations.[102] One case involved Eli Lilly and Company's antipsychotic Zyprexa, and the other involved Bextra. In the Bextra case, the government also charged Pfizer with illegally marketing another antipsychotic, Geodon.[102] In addition, Astrazeneca faces numerous personal-injury lawsuits from former users of Seroquel (quetiapine), amidst federal investigations of its marketing practices.[103] By expanding the conditions for which they were indicated, Astrazeneca's Seroquel and Eli Lilly's Zyprexa had become the biggest selling antipsychotics in 2008 with global sales of $5.5 billion and $5.4 billion respectively.[104]

Harvard medical professor Joseph Biederman conducted research on bipolar disorder in children that led to an increase in such diagnoses. A 2008 Senate investigation found that Biederman also received $1.6 million in speaking and consulting fees between 2000 and 2007— some of them undisclosed to Harvard— from companies including the makers of antipsychotic drugs prescribed for children with bipolar disorder. Johnson & Johnson gave more than $700,000 to a research center that was headed by Biederman from 2002 to 2005, where research was conducted, in part, on Risperdal, the company's antipsychotic drug. Biederman has responded saying that the money did not influence him and that he did not promote a specific diagnosis or treatment.[102]

In 2004, University of Minnesota research participant Dan Markingson committed suicide while enrolled in an industry-sponsored pharmaceutical trial comparing three FDA-approved atypical antipsychotics: Seroquel (quetiapine), Zyprexa (olanzapine), and Risperdal (risperidone). Writing on the circumstances surrounding Markingson's death in the study, which was designed and funded by Seroquel manufacturer AstraZeneca, University of Minnesota Professor of Bioethics Carl Elliott noted that Markingson was enrolled in the study against the wishes of his mother, Mary Weiss, and that he was forced to choose between enrolling in the study or being involuntarily committed to a state mental institution.[105] Further investigation revealed financial ties to AstraZeneca by Markingson's psychiatrist, Dr. Stephen C. Olson, oversights and biases in AstraZeneca's trial design, and the inadequacy of university Institutional Review Board (IRB) protections for research subjects.[106] A 2005 FDA investigation cleared the university. Nonetheless, controversy around the case has continued. Mother Jones resulted in a group of university faculty members sending a public letter to the university Board of Regents urging an external investigation into Markingson's death.[107]

Pharmaceutical companies have also been accused of attempting to set the mental health agenda through activities such as funding consumer advocacy groups.[108]

In an effort to reduce the potential for hidden conflicts of interest between researchers and pharmaceutical companies, the US Government issued a mandate in 2012 requiring that drug manufacturers receiving funds under the Medicare and Medicaid programs collect data, and make public, all gifts to doctors and hospitals.[109]: 317 

Main article: Experimentation on prisoners

Anti-psychiatry

The term anti-psychiatry was coined by psychiatrist David Cooper in 1967 and is understood in current psychiatry to mean opposition to psychiatry's perceived role in aspects of treatment.[110] The anti-psychiatry message is that psychiatric treatments are "ultimately more damaging than helpful to patients“. Psychiatry is seen to involve an "unequal power relationship between doctor and patient“, and advocates of anti-psychiatry claim a subjective diagnostic process leaves much room for opinions and interpretations.[110][111] Every society, including liberal Western society, permits compulsory treatment of mental patients.[110] The World Health Organization (WHO) recognizes that "poor quality services and human rights violations in mental health and social care facilities are still an everyday occurrence in many places", but has recently taken steps to improve the situation globally.[112]

Electroconvulsive therapy is a therapy method, which was used widely between the 1930s and 1960s and is, in a modified form, still in use today. Valium and other sedatives have arguably been over-prescribed, leading to a claimed epidemic of dependence. These are a few of the arguments that the anti-psychiatry movement use to highlight the harms of psychiatric practice.

Multiple authors have come to personify the movement against psychiatry, two of which are or have been practicing psychiatrists. The most influential was R.D. Laing, who wrote a series of books, including, The Divided Self. Thomas Szasz rose to fame with the book The Myth of Mental Illness. Michael Foucault challenged the very basis of psychiatric practice and cast it as repressive and controlling. The founder of the non-psychiatric approach to psychological suffering is Giorgio Antonucci.

Divergence within psychiatry generated the anti-psychiatry movement in the 1960s and 1970s, and is still present. Issues remaining relevant in contemporary psychiatry are questions of freedom versus coercion, mind versus brain, nature versus nurture, and the right to be different.[110]

Psychiatric survivors movement

The psychiatric survivors movement[113] arose out of the civil rights era of the late 1960s and early 1970s and the personal histories of psychiatric abuse experienced by some ex-patients rather than the intradisciplinary discourse of antipsychiatry.[114] The key text in the intellectual development of the survivor movement, at least in the United States, was Judi Chamberlin's 1978 text, On Our Own: Patient Controlled Alternatives to the Mental Health System.[113][115] Chamberlin was an ex-patient and co-founder of the Mental Patients' Liberation Front.[116] Coalescing around the ex-patient newsletter Dendron,[117] in late 1988 leaders from several of the main national and grassroots psychiatric survivor groups felt that an independent, human rights coalition focused on problems in the mental health system was necessary. That year the Support Coalition International (SCI) was formed. SCI's first public action was to stage a counter-conference and protest in New York City, in May, 1990, at the same time as (and directly outside of) the American Psychiatric Association's annual meeting.[118] In 2005, the SCI changed its name to Mind Freedom International with David W. Oaks as its director.[114]

See also

References

  1. ^ Frances A (6 August 2013). "The new crisis of confidence in psychiatric diagnosis". Annals of Internal Medicine. 159 (2): 221–222. doi:10.7326/0003-4819-159-3-201308060-00655. PMID 23685989.
  2. ^ Moncrieff, Joanna (2010-11-01). "Psychiatric diagnosis as a political device". Social Theory & Health. 8 (4): 370–382. doi:10.1057/sth.2009.11. ISSN 1477-822X. S2CID 14758899.
  3. ^ Shorter, Edward; Healy, David (2007). "8". Shock Therapy: A History of Electroconvulsive Treatment in Mental Illness. Rutgers University Press. ISBN 978-0-8135-4169-3.
  4. ^ Moncrieff, J. (2013-09-15). The Bitterest Pills: The Troubling Story of Antipsychotic Drugs. Springer. p. 132. ISBN 978-1-137-27744-2.
  5. ^ a b Lévêque, Marc (2016-09-03). Psychosurgery: New Techniques for Brain Disorders. Springer International Publishing. ISBN 978-3-319-34595-6.
  6. ^ Doroshow, Deborah Blythe (2007). "Performing a cure for schizophrenia: insulin coma therapy on the wards". Journal of the History of Medicine and Allied Sciences. 62 (2): 213–243. doi:10.1093/jhmas/jrl044. ISSN 0022-5045. PMID 17105748.
  7. ^ Robertson, Michael; Walter, Garry (2013-09-26). Ethics and Mental Health: The Patient, Profession and Community. CRC Press. ISBN 978-1-4441-6865-5.
  8. ^ Kirk, Stuart A.; Kutchins, Herb (1994). "The Myth of the Reliability of DSM". Journal of Mind and Behavior. 15 (1&2): 71–86. Archived from the original on 2008-03-07. Reprinted by Academy for the Study of the Psychoanalytic Arts.
  9. ^ Kirk, Stuart (2013). Mad science : psychiatric coercion, diagnosis, and drugs. New Brunswick, N.J: Transaction Publishers. p. 185. ISBN 978-1-4128-4976-0. OCLC 808769553.
  10. ^ Kirk, Stuart A. (2013). Mad Science: Psychiatric Coercion, Diagnosis, and Drugs. Transaction Publishers.
  11. ^ Frances A (6 August 2013). "The new crisis of confidence in psychiatric diagnosis". Annals of Internal Medicine. 159 (2): 221–222. doi:10.7326/0003-4819-159-3-201308060-00655. PMID 23685989.
  12. ^ Frances A (January 2013). "The past, present and future of psychiatric diagnosis". World Psychiatry. 12 (2): 111–112. doi:10.1002/wps.20027. PMC 3683254. PMID 23737411.
  13. ^ White, Kevin (2002). An introduction to the sociology of health and illness. SAGE. p. 42. ISBN 978-0-7619-6400-1.
  14. ^ Conrad P (October 1975). "The discovery of hyperkinesis: notes on the medicalization of deviant behavior". Soc Probl. 23 (1): 12–21. doi:10.1525/sp.1975.23.1.03a00020. PMID 11662312.
  15. ^ Helman, Cecil (2007). Culture, Health and Illness. London: Arnold. ISBN 978-0-340-91450-2.
  16. ^ Filc D (September 2004). "The medical text: between biomedicine and hegemony". Soc Sci Med. 59 (6): 1275–85. doi:10.1016/j.socscimed.2004.01.003. PMID 15210098.
  17. ^ Ajai R Singh, Shakuntala A Singh, 2005, "Medicine as a corporate enterprise, patient welfare centered profession, or patient welfare centered professional enterprise?" Mens Sana Monographs, 3(2), p19-51
  18. ^ Ajai R Singh, Shakuntala A Singh, 2005, "The connection between academia and industry", Mens Sana Monographs, 3(1), p5-35
  19. ^ Ajai R Singh, Shakuntala A Singh, 2005, "Public welfare agenda or corporate research agenda?", Mens Sana Monographs, 3(1), p41-80.
  20. ^ Noll, Richard (2007). The encyclopedia of schizophrenia and other psychotic disorders. Infobase Publishing. p. 3. ISBN 978-0-8160-6405-2.
  21. ^ a b c British Medical Association (1992). Medicine betrayed: the participation of doctors in human rights abuses. Zed Books. p. 65–66. ISBN 978-1-85649-104-4.
  22. ^ Malterud, Kirsti; Hunskaar, Steinar (2002). Chronic myofascial pain: a patient-centered approach. Radcliffe Publishing. p. 94. ISBN 978-1-85775-947-1.
  23. ^ a b Veenhoven, Willem; Ewing, Winifred; Samenlevingen, Stichting (1975). Case studies on human rights and fundamental freedoms: a world survey. Martinus Nijhoff Publishers. p. 29. ISBN 978-90-247-1780-4.
  24. ^ Shah R, Basu D (July–September 2010). "Coercion in psychiatric care: Global and Indian perspective". Indian Journal of Psychiatry. 52 (3): 203–206. doi:10.4103/0019-5545.70971. PMC 2990818. PMID 21180403.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  25. ^ Declan, Lyons; Art, O'Malley (1 December 2002). "The labelling of dissent — politics and psychiatry behind the Great Wall". Psychiatric Bulletin. 26 (12): 443–444. doi:10.1192/pb.26.12.443.
  26. ^ Voren, Robert van (January 2010). "Political Abuse of Psychiatry—An Historical Overview". Schizophrenia Bulletin. 36 (1): 33–35. doi:10.1093/schbul/sbp119. PMC 2800147. PMID 19892821.
  27. ^ Voren, Robert van (2013). Psychiatry as a tool of coercion in post-Soviet countries (PDF). The European Parliament. doi:10.2861/28281. ISBN 978-92-823-4595-5.
  28. ^ Katona, Cornelius; Robertson, Mary (2005). Psychiatry at a glance. Wiley-Blackwell. p. 77. ISBN 978-1-4051-2404-1.
  29. ^ a b c d e f g Geller, Jeffrey (2020-06-23). "Structural Racism in American Psychiatry and APA: Part 1". Psychiatric News. doi:10.1176/appi.pn.2020.7a18.
  30. ^ a b c Geller, Jeffrey (2020-07-08). "Structural Racism in American Psychiatry and APA: Part 2". Psychiatric News. doi:10.1176/appi.pn.2020.7b27.
  31. ^ Geller, Jeffrey (2020-07-28). "Structural Racism in American Psychiatry and APA: Part 3". Psychiatric News. doi:10.1176/appi.pn.2020.8a16.
  32. ^ a b Geller, Jeffrey (2020-08-13). "Structural Racism in American Psychiatry and APA: Part 4". Psychiatric News. doi:10.1176/appi.pn.2020.8b13.
  33. ^ a b Geller, Jeffrey (2020-08-26). "Structural Racism in American Psychiatry and APA: Part 5". Psychiatric News. doi:10.1176/appi.pn.2020.9a20.
  34. ^ a b c Geller, Jeffrey (2020-09-09). "Structural Racism in American Psychiatry and APA: Part 6". Psychiatric News. doi:10.1176/appi.pn.2020.9b17.
  35. ^ a b c d Geller, Jeffrey (2020-09-22). "Structural Racism in American Psychiatry and APA: Part 7". Psychiatric News. doi:10.1176/appi.pn.2020.10a33.
  36. ^ Wyse, Rhea; Hwang, Wei-Ting; Ahmed, Awad A.; Richards, Erica; Deville, Curtiland (2020-10-01). "Diversity by Race, Ethnicity, and Sex within the US Psychiatry Physician Workforce". Academic Psychiatry. 44 (5): 523–530. doi:10.1007/s40596-020-01276-z. ISSN 1545-7230.
  37. ^ Helen Spandler, Sarah Carr. "Hidden from history? A brief modern history of the psychiatric "treatment" of lesbian and bisexual women in England". The Lancet.
  38. ^ "15 new mental illnesses in the DSM-5". Market watch.
  39. ^ Joel Paris (2020). Overdiagnosis in Psychiatry: How Modern Psychiatry Lost Its Way While Creating a Diagnosis for Almost All of Life's Misfortunes. Oxford University Press. ISBN 978-0-19-750427-7.
  40. ^ "Is ADHD overdiagnosed and overtreated?". 16 March 2017. Archived from the original on 16 March 2017.
  41. ^ Robertson, Michael; Walter, Garry (2013-09-26). Ethics and Mental Health: The Patient, Profession and Community. CRC Press. ISBN 978-1-4441-6865-5.
  42. ^ Burns, Tom (2006). Psychiatry: A very short introduction. Oxford University Press. ISBN 978-0-19-280727-4.
  43. ^ Frances A (January 2013). "The past, present and future of psychiatric diagnosis". World Psychiatry. 12 (2): 111–112. doi:10.1002/wps.20027. PMC 3683254. PMID 23737411.
  44. ^ Nasrallah, Henry A. (December 2011). "The antipsychiatry movement: Who and why" (PDF). Current Psychiatry. 10 (12): 4, 6, 53. Archived from the original (PDF) on 2015-02-07. Retrieved 2015-06-03.
  45. ^ a b Boyle, Mary (1990-01-01). Schizophrenia: A Scientific Delusion?. Routledge. ISBN 978-0-415-04096-9.
  46. ^ a b Tsuang MT, Stone WS, Faraone SV (2000). "Toward reformulating the diagnosis of schizophrenia". American Journal of Psychiatry. 157 (7): 1041–50. doi:10.1176/appi.ajp.157.7.1041. PMID 10873908.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  47. ^ Peralta V, Cuesta MJ (June 2007). "A dimensional and categorical architecture for the classification of psychotic disorders". World Psychiatry. 6 (2): 100–1. PMC 2219908. PMID 18235866.{{cite journal}}: CS1 maint: date and year (link)
  48. ^ Verdoux H, van Os J (2002). "Psychotic symptoms in non-clinical populations and the continuum of psychosis". Schizophrenia Research. 54 (1–2): 59–65. doi:10.1016/S0920-9964(01)00352-8. PMID 11853979.
  49. ^ Johns LC, van Os J (2001). "The continuity of psychotic experiences in the general population". Clinical Psychology Review. 21 (8): 1125–41. doi:10.1016/S0272-7358(01)00103-9. PMID 11702510.
  50. ^ Peters ER, Day S, McKenna J, Orbach G (2005). "Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI)". Schizophrenia Bulletin. 30 (4): 1005–22. doi:10.1093/oxfordjournals.schbul.a007116. PMID 15954204.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  51. ^ Jones E (1999). "The Phenomenology of Abnormal Belief: A Philosophical and Psychiatric Inquiry". Philosophy, Psychiatry and Psychology. 6 (1): 1–16.
  52. ^ David AS (1999). "On the impossibility of defining delusions". Philosophy, Psychiatry and Psychology. 6 (1): 17–20. Retrieved 2008-02-24.
  53. ^ Ghaemi SN (1999). "An Empirical Approach to Understanding Delusions". Philosophy, Psychiatry and Psychology. 6 (1): 21–24. Retrieved 2008-02-24.
  54. ^ Andreasen NC (March 2000). "Schizophrenia: the fundamental questions". Brain Res. Brain Res. Rev. 31 (2–3): 106–12. doi:10.1016/S0165-0173(99)00027-2. PMID 10719138.{{cite journal}}: CS1 maint: date and year (link)
  55. ^ Andreasen NC (September 1999). "A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly". Archives of General Psychiatry. 56 (9): 781–7. doi:10.1001/archpsyc.56.9.781. PMID 12884883.{{cite journal}}: CS1 maint: date and year (link)
  56. ^ a b Jansson LB, Parnas J (September 2007). "Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?". Schizophr Bull. 33 (5): 1178–200. doi:10.1093/schbul/sbl065. PMC 3304082. PMID 17158508.{{cite journal}}: CS1 maint: date and year (link)
  57. ^ Green MF, Nuechterlein KH (1999). "Should schizophrenia be treated as a neurocognitive disorder?". Schizophr Bull. 25 (2): 309–19. PMID 10416733.
  58. ^ Green, Michael (2001). Schizophrenia revealed: from neurons to social interactions. New York: W.W. Norton. ISBN 0-393-70334-7. {{cite book}}: Unknown parameter |lay-source= ignored (help); Unknown parameter |lay-url= ignored (help)
  59. ^ Lake CR, Hurwitz N (July 2007). "Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease—there is no schizoaffective disorder". Curr Opin Psychiatry. 20 (4): 365–79. doi:10.1097/YCO.0b013e3281a305ab. PMID 17551352.{{cite journal}}: CS1 maint: date and year (link)
  60. ^ Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V (February 2008). "Schizoaffective disorder: diagnostic issues and future recommendations". Bipolar Disorders. 10 (1 Pt 2): 215–30. doi:10.1111/j.1399-5618.2007.00564.x. PMID 18199238.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  61. ^ Craddock N, Owen MJ (May 2005). "The beginning of the end for the Kraepelinian dichotomy". Br J Psychiatry. 186: 364–6. doi:10.1192/bjp.186.5.364. PMID 15863738.{{cite journal}}: CS1 maint: date and year (link)
  62. ^ a b Parrillo, VN (2008), Encyclopedia of Social Problems, Volume 1, SAGE, p. 63, ISBN 978-1-4129-4165-5, retrieved 7 Apr 2016
  63. ^ a b Sim MG, Hulse G, Khong E (August 2004). "When the child with ADHD grows up". Australian Family Physician. 33 (8): 615–8. PMID 15373378.
  64. ^ Foreman DM (February 2006). "Attention deficit hyperactivity disorder: legal and ethical aspects". Archives of Disease in Childhood. 91 (2): 192–194. doi:10.1136/adc.2004.064576. PMC 2082674. PMID 16428370.
  65. ^ a b National Collaborating Centre for Mental Health (2009), Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults, British Psychological Society, pp. 19–27, 38, 130, 133, 317, ISBN 978-1-85433-471-8
  66. ^ Faraone, Stephen V (2005). "The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder". Eur Child Adolesc Psychiatry. 14 (1): 1–10. doi:10.1007/s00787-005-0429-z. PMID 15756510. S2CID 143646869.
  67. ^ Boseley, Sarah (30 September 2010). "Hyperactive children may suffer from genetic disorder, says study". The Guardian.
  68. ^ a b Cormier E (October 2008). "Attention deficit/hyperactivity disorder: a review and update". J Pediatr Nurs. 23 (5): 345–357. doi:10.1016/j.pedn.2008.01.003. PMID 18804015.
  69. ^ Schwarz, Alan (14 December 2013). "The Selling of Attention Deficit Disorder". The New York Times. No. 14 December 2013. Retrieved 26 February 2015.
  70. ^ Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP (2014). "Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature". Prim Care Companion CNS Disord. 16 (3). doi:10.4088/PCC.13r01600. PMC 4195639. PMID 25317367. Reports indicate that ADHD affects 2.5%–5% of adults in the general population,5–8 compared with 5%–7% of children.9,10 ... However, fewer than 20% of adults with ADHD are currently diagnosed and/or treated by psychiatrists.7,15,16
  71. ^ Elder TE (September 2010). "The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates". J Health Econ. 29 (5): 641–656. doi:10.1016/j.jhealeco.2010.06.003. PMC 2933294. PMID 20638739.
  72. ^ a b c Mayes R, Bagwell C, Erkulwater JL (2009). Medicating Children: ADHD and Pediatric Mental Health (illustrated ed.). Harvard University Press. pp. 4–24. ISBN 978-0-674-03163-0.
  73. ^ Silver LB (2004). Attention-deficit/hyperactivity disorder (3rd ed.). American Psychiatric Publishing. pp. 4–7. ISBN 978-1-58562-131-6.
  74. ^ Schonwald A, Lechner E (April 2006). "Attention deficit/hyperactivity disorder: complexities and controversies". Curr. Opin. Pediatr. 18 (2): 189–195. doi:10.1097/01.mop.0000193302.70882.70. PMID 16601502. S2CID 27286123.
  75. ^ Saletan, William (12 January 2009). "Doping Deficit Disorder. Need performance-enhancing drugs? Claim ADHD". Slate. Archived from the original on 21 May 2009. Retrieved 2 May 2009.
  76. ^ Lévêque, Marc (2016-09-03). Psychosurgery: New Techniques for Brain Disorders. Springer International Publishing. ISBN 978-3-319-34595-6.
  77. ^ "The Nobel Prize in Physiology or Medicine 1949". NobelPrize.org. Retrieved 2021-02-19.
  78. ^ OpenStax; Learning, Lumen, "Biomedical Therapies", General Psychology, retrieved 2021-02-19
  79. ^ Larry O, Gostin (1980). "Ethical considerations of psychosurgery: The unhappy legacy of the prefrontal lobotomy". Journal of Medical Ethics. 6 (3): 149–154. doi:10.1136/jme.6.3.149. PMC 1154827. PMID 7420386.
  80. ^ Ma, Shuo; Zhang, Chencheng; Yuan, Ti-fei; Steele, Douglas; Voon, Valerie; Sun, Bomin (2020-03-01). "Neurosurgical treatment for addiction: lessons from an untold story in China and a path forward". National Science Review. 7 (3): 702–712. doi:10.1093/nsr/nwz207. ISSN 2095-5138. PMC 8288968.
  81. ^ Diefenbach, Gretchen J.; Diefenbach, Donald; Baumeister, Alan; West, Mark (1999-04-01). "Portrayal of Lobotomy in the Popular Press: 1935–1960". Journal of the History of the Neurosciences. 8 (1): 60–69. doi:10.1076/jhin.8.1.60.1766. ISSN 0964-704X. PMID 11624138.
  82. ^ a b c d Johnson, Jenell (2014-10-17). American Lobotomy: A Rhetorical History. University of Michigan Press. ISBN 978-0-472-11944-8.
  83. ^ Tang, Wai-Kwong; Ungvari, Gabor S. (January 2001). "Asystole during electroconvulsive therapy: a case report". Australian and New Zealand Journal of Psychiatry. 35 (3): 382–385. doi:10.1046/j.1440-1614.2001.00892.x. PMID 11437814. S2CID 24775828.
  84. ^ Otsuka, H; Shikama, H; Saito, T; Ishikawa, T; Kemmotsu, O (August 2000). "[Asystole during electroconvulsive therapy in a patient with depression and myasthenia gravis]". Masui. 49 (8): 893–5. PMID 10998885.
  85. ^ a b c Shorter 1997, p. 282.
  86. ^ Hales, E; Yudofsky, JA, eds. (2003), The American Psychiatric Press Textbook of Psychiatry (4th ed.), Washington, DC: American Psychiatric Publishing, p. 444, ISBN 978-1-58562-032-6, OCLC 49576699
  87. ^ Weiner, Richard D.; Reti, Irving M. (2017-03-04). "Key updates in the clinical application of electroconvulsive therapy". International Review of Psychiatry. 29 (2): 54–62. doi:10.1080/09540261.2017.1309362. ISSN 0954-0261. PMID 28406327. S2CID 205645744.
  88. ^ a b Fink, M; Taylor, MA (18 July 2007). "Electroconvulsive therapy: evidence and challenges". JAMA. 298 (3): 330–2. doi:10.1001/jama.298.3.330. PMID 17635894.
  89. ^ "Guidance", Depression in adults: The treatment and management of depression in adults, London, UK: National Institute for Health and Care Excellence, October 2009
  90. ^ The use of electroconvulsive therapy: Understanding NICE guidance – information for service users, their advocates and carers, and the public, London, UK: National Institute for Health and Care Excellence, April 2003, ISBN 978-1-84257-284-9, archived from the original (PDF) on 2014-11-29, retrieved 2015-06-03
  91. ^ Kennedy, SH; Milev, R; Giacobbe, P; Ramasubbu, R; Lam, RW; Parikh, SV; Patten, SB; Ravindran, AV (October 2009). "Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies". J Affect Disord. 117 (Suppl 1): S44–53. doi:10.1016/j.jad.2009.06.039. PMID 19656575.
  92. ^ Weiner, Richard D.; Reti, Irving M. (2017-03-04). "Key updates in the clinical application of electroconvulsive therapy". International Review of Psychiatry. 29 (2): 54–62. doi:10.1080/09540261.2017.1309362. ISSN 0954-0261. PMID 28406327. S2CID 205645744. ECT is associated with both anterograde and retrograde amnesia. Studies utilizing objective measures of assessing anterograde amnesia have consistently demonstrated that any such abnormalities disappear within several months following completion of an acute ECT course. Several recent studies have even demonstrated improvement in cognitive function, compared to baseline, several weeks to months after successful treatment with ECT. An even more recently published study that reviewed 10 years of cognitive performance data in relation to ECT concluded that there is no evidence of cumulative cognitive deficits associated with repeated ECT courses.
  93. ^ Rose, D; Fleischmann, P; Wykes, T; Leese, M; Bindman, J (21 June 2003). "Patients' perspectives on electroconvulsive therapy: systematic review". BMJ. 326 (7403): 1363. doi:10.1136/bmj.326.7403.1363. PMC 162130. PMID 12816822.
  94. ^ a b Burns, Tom (2006). Psychiatry: A very short introduction. Oxford University Press. ISBN 978-0-19-280727-4.
  95. ^ a b c "The Relationship between Psychiatrists, College of Psychiatrists of Ireland and the Pharmaceutical Industry: Position Paper EAP04/2013". College of Psychiatrists of Ireland. December 2012. Archived from the original (PDF) on 2014-11-04. Retrieved 2013-04-22.
  96. ^ James, Adam (2 March 2008). "Myth of the antipsychotic". The Guardian. Guardian News and Media Limited. Retrieved 27 July 2012.
  97. ^ Moncrieff J (2006). "Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem". Med. Hypotheses. 67 (3): 517–23. doi:10.1016/j.mehy.2006.03.009. PMID 16632226.
  98. ^ GPs under 'pressure' to issue neuroleptics, claims professor, Chemist + Druggist, 15 January 2009
  99. ^ Nick Triggle (12 November 2009). "Dementia drug use 'killing many'". BBC. Retrieved 2013-05-07.
  100. ^ "UK study warns against antipsychotics for dementia". reuters. Nov 12, 2009. Archived from the original on 2014-07-20. Retrieved 2013-05-07.
  101. ^ Hilzenrath, David S. (16 January 2010). "Justice suit accuses Johnson & Johnson of paying kickbacks". The Washington Post. Retrieved 17 January 2010.
  102. ^ a b c Wilson, Duff (October 2, 2010). "Side Effects May Include Lawsuits". The New York Times.
  103. ^ DUFF WILSON (27 February 2009). "Drug Maker's E-Mail Released in Seroquel Lawsuit". The New York Times. Retrieved 27 July 2012.
  104. ^ Pipelineantipsychotic drugs to drive next market evolution (2009). Healthcarefinancenews.com (7 August 2009).
  105. ^ Elliott, Carl (September/October 2010). "The deadly corruption of clinical trials." Mother Jones
  106. ^ Carl (2012-11-23). "Dan Markingson Investigation". Retrieved February 14, 2016.
  107. ^ "U of M Board of Regents Markingson Letter". Scribd. Retrieved February 14, 2016.
  108. ^ Gosden R, Beder S (2001). "Pharmaceutical industry agenda setting in mental health policies". Ethical Human Sciences and Services. 3 (3): 147–59. doi:10.1891/1523-150X.3.3.147. PMID 15278977. Archived from the original on 2010-04-30. Retrieved 2016-06-22.
  109. ^ Kirk, Stuart A. (2013). Mad Science: Psychiatric Coercion, Diagnosis, and Drugs. Transaction Publishers.
  110. ^ a b c d Burns, Tom (2006). Psychiatry: A very short introduction. Oxford University Press. ISBN 978-0-19-280727-4.
  111. ^ Nasrallah, Henry A. (December 2011). "The antipsychiatry movement: Who and why" (PDF). Current Psychiatry. 10 (12): 4, 6, 53. Archived from the original (PDF) on 2015-02-07. Retrieved 2015-06-03.
  112. ^ "WHO gives countries tools to help stop abuse of people with mental health conditions". WHO. Archived from the original on March 14, 2014. Retrieved 12 June 2014.
  113. ^ a b Corrigan, Patrick W.; David Roe; Hector W. H. Tsang (2011-05-23). Challenging the Stigma of Mental Illness: Lessons for Therapists and Advocates. John Wiley and Sons. ISBN 978-1-119-99612-5.
  114. ^ a b Oaks D (2006-08-01). "The evolution of the consumer movement". Psychiatric Services. 57 (8): 1212. doi:10.1176/appi.ps.57.8.1212. PMID 16870979.
  115. ^ Chamberlin, Judi (1978). On Our Own: Patient-Controlled Alternatives to the Mental Health System. New York: Hawthorne. ISBN 978-0-8015-5523-7.
  116. ^ Rissmiller DJ, Rissmiller JH (2006-06-01). "Evolution of the antipsychiatry movement into mental health consumerism". Psychiatric Services. 57 (6): 863–6 [865]. doi:10.1176/appi.ps.57.6.863. PMID 16754765. S2CID 19635873.
  117. ^ Ludwig, Gregory (2006-08-01). "Letter". Psychiatric Services. 57 (8): 1213. doi:10.1176/appi.ps.57.8.1213. PMID 16870981.
  118. ^ About Us — MFI Portal
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=User:Lr775/Controversies_about_psychiatry&oldid=1081703996"